• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

弥散性血管内凝血作为冠状病毒-19 疾病的一种表现形式。临床病例。

Disseminated intravascular coagulation as a form of presentation of coronavirus-19 disease. Clinical case.

机构信息

Servicio de Anestesiología, Reanimación y Tratamiento del Dolor, Hospital Clínico de Barcelona, Barcelona, España.

Servicio de Anestesiología, Reanimación y Tratamiento del Dolor, Hospital Clínico de Barcelona, Barcelona, España.

出版信息

Rev Esp Anestesiol Reanim (Engl Ed). 2021 Jan;68(1):41-45. doi: 10.1016/j.redar.2020.05.010. Epub 2020 May 25.

DOI:10.1016/j.redar.2020.05.010
PMID:33160686
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7247485/
Abstract

The covid-19 disease (coronavirus disease 2019) is a novel disease causing a world pandemic. Its presentation varies from an asymptomatic infection to a pneumonia with acute respiratory distress syndrome. We present a case presenting initially as a covid-19 pneumonia together with a disseminated intravascular coagulopathy consisting of arterial and venous thrombosis in different locations and a shock requiring admission in the intensive care unit. The abnormal coagulation test in covid-19 patients have been described since the first cases observed in Wuhan, China, as well as an increased incidence of venous thrombosis. On the contrary, a higher incidence of arterial thrombosis has not been described in these patients. The unusual case we present could be a manifestation of this altered tests.

摘要

新型冠状病毒肺炎(COVID-19)是一种新型疾病,引发了全球性大流行。其临床表现从无症状感染到伴有急性呼吸窘迫综合征的肺炎不等。我们报告了一例最初表现为 COVID-19 肺炎的病例,同时伴有弥散性血管内凝血,包括不同部位的动脉和静脉血栓形成以及需要入住重症监护病房的休克。自中国武汉首次观察到 COVID-19 病例以来,已描述了 COVID-19 患者的异常凝血试验,以及静脉血栓形成的发生率增加。相反,这些患者的动脉血栓形成发生率并没有增加。我们报告的这个不寻常病例可能是这些改变的检验结果的一种表现。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc32/7247485/bd1fe875ee47/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc32/7247485/8feac13a64e0/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc32/7247485/bd1fe875ee47/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc32/7247485/8feac13a64e0/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc32/7247485/bd1fe875ee47/gr2_lrg.jpg

相似文献

1
Disseminated intravascular coagulation as a form of presentation of coronavirus-19 disease. Clinical case.弥散性血管内凝血作为冠状病毒-19 疾病的一种表现形式。临床病例。
Rev Esp Anestesiol Reanim (Engl Ed). 2021 Jan;68(1):41-45. doi: 10.1016/j.redar.2020.05.010. Epub 2020 May 25.
2
A unique tale of COVID-19 induced concomitant overt disseminated intravascular coagulation and acute bilateral pulmonary embolism.COVID-19 引起的同时发生的显性弥漫性血管内凝血和急性双侧肺栓塞的独特病例报告。
Int J Infect Dis. 2021 Mar;104:568-571. doi: 10.1016/j.ijid.2021.01.040. Epub 2021 Jan 21.
3
A proposal for the management of COVID-19-induced coagulopathy in adults.成人 COVID-19 诱导性凝血病管理建议。
Gac Med Mex. 2021;157(2):201-206. doi: 10.24875/GMM.20000930.
4
COVID-19 coagulopathy: is it disseminated intravascular coagulation?COVID-19 凝血功能障碍:是弥散性血管内凝血吗?
Intern Emerg Med. 2021 Mar;16(2):309-312. doi: 10.1007/s11739-020-02601-y. Epub 2020 Dec 24.
5
DIC, SIC or CAC - the haemostatic profile in COVID-19 patients hospitalised in the intensive care unit: a single-centre retrospective analysis.DIC、SIC 或 CAC - 重症监护病房 COVID-19 患者的止血谱:一项单中心回顾性分析。
Anaesthesiol Intensive Ther. 2021;53(2):108-114. doi: 10.5114/ait.2021.106691.
6
Microvascular thrombosis and clinical implications.微血管血栓形成及其临床意义。
Med Clin (Barc). 2021 Jun 25;156(12):609-614. doi: 10.1016/j.medcli.2020.12.042. Epub 2021 Apr 16.
7
Coagulopathy of Coronavirus Disease 2019.新型冠状病毒疾病的凝血功能障碍。
Crit Care Med. 2020 Sep;48(9):1358-1364. doi: 10.1097/CCM.0000000000004458.
8
COVID-19-associated coagulopathy and disseminated intravascular coagulation.COVID-19 相关凝血功能障碍和弥散性血管内凝血。
Int J Hematol. 2021 Jan;113(1):45-57. doi: 10.1007/s12185-020-03029-y. Epub 2020 Nov 7.
9
COVID-19 versus HIT hypercoagulability.COVID-19 与 HIT 高凝状态。
Thromb Res. 2020 Dec;196:38-51. doi: 10.1016/j.thromres.2020.08.017. Epub 2020 Aug 10.
10
Haematological characteristics and risk factors in the classification and prognosis evaluation of COVID-19: a retrospective cohort study.新冠病毒肺炎分类及预后评估中的血液学特征与危险因素:一项回顾性队列研究
Lancet Haematol. 2020 Sep;7(9):e671-e678. doi: 10.1016/S2352-3026(20)30217-9. Epub 2020 Jul 10.

本文引用的文献

1
SEDAR-SEMICYUC consensus recommendations on the management of haemostasis disorders in severely ill patients with COVID-19 infection.SEDAR-SEMICYUC关于COVID-19感染重症患者止血障碍管理的共识建议。
Rev Esp Anestesiol Reanim (Engl Ed). 2020 Aug-Sep;67(7):391-399. doi: 10.1016/j.redar.2020.05.007. Epub 2020 May 23.
2
Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy.抗凝治疗与伴有凝血功能障碍的严重 2019 冠状病毒病患者的死亡率降低相关。
J Thromb Haemost. 2020 May;18(5):1094-1099. doi: 10.1111/jth.14817. Epub 2020 Apr 27.
3
Thrombocytopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: A meta-analysis.
血小板减少症与严重的 2019 年冠状病毒病(COVID-19)感染相关:一项荟萃分析。
Clin Chim Acta. 2020 Jul;506:145-148. doi: 10.1016/j.cca.2020.03.022. Epub 2020 Mar 13.
4
Prominent changes in blood coagulation of patients with SARS-CoV-2 infection.SARS-CoV-2 感染患者凝血功能的显著变化。
Clin Chem Lab Med. 2020 Jun 25;58(7):1116-1120. doi: 10.1515/cclm-2020-0188.
5
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study.中国武汉成人 COVID-19 住院患者的临床病程和死亡危险因素:一项回顾性队列研究。
Lancet. 2020 Mar 28;395(10229):1054-1062. doi: 10.1016/S0140-6736(20)30566-3. Epub 2020 Mar 11.
6
Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia.异常的凝血参数与新型冠状病毒肺炎患者的预后不良有关。
J Thromb Haemost. 2020 Apr;18(4):844-847. doi: 10.1111/jth.14768. Epub 2020 Mar 13.
7
A Novel Coronavirus from Patients with Pneumonia in China, 2019.2019 年中国肺炎患者中的一种新型冠状病毒。
N Engl J Med. 2020 Feb 20;382(8):727-733. doi: 10.1056/NEJMoa2001017. Epub 2020 Jan 24.
8
The coagulopathy of acute sepsis.急性脓毒症的凝血病
Curr Opin Anaesthesiol. 2015 Apr;28(2):227-36. doi: 10.1097/ACO.0000000000000163.
9
Use of soluble fibrin antigen instead of D-dimer as fibrin-related marker may enhance the prognostic power of the ISTH overt DIC score.使用可溶性纤维蛋白抗原而非D-二聚体作为纤维蛋白相关标志物,可能会增强国际血栓与止血学会显性弥散性血管内凝血(ISTH overt DIC)评分的预后评估能力。
Thromb Haemost. 2004 Apr;91(4):812-8. doi: 10.1160/TH03-09-0577.